MA
PROK icon

MYDA Advisors’s ProKidney PROK Stock Holding History

MYDA Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$768K Sell
428,775
-11,225
-3% -$23.8K 0.13% 115
2025
Q4 		$986K Sell
440,000
-10,000
-2% -$26.3K 0.19% 86
2025
Q3 		$1.09M Buy
+450,000
New +$1.2M 0.24% 89
2022
Q3 		– Sell
-232,000
Closed -$2.31M – 195
2022
Q2 		$2.31M Hold
232,000
– – 0.65% 35
2022
Q1 		$2.3M Hold
232,000
– – 0.91% 36
2021
Q4 		$2.3M Sell
232,000
-723
-0.3% -$7.15K 0.61% 46
2021
Q3 		$2.28M Hold
232,723
– – 0.64% 42
2021
Q2 		$2.35M Buy
+232,723
New +$2.35M 0.59% 48

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MYDA Advisors's PROK Position: Q1 2026 in Review

MYDA Advisors reduced its ProKidney (PROK) stake by 2.6% in Q1 2026, selling an estimated $23.8K and leaving 428,775 shares worth $768K. The position accounts for 0.13% of the portfolio, ranked #115.

MYDA Advisors first reported a position in PROK in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.35M in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • MYDA Advisors held 428,775 shares of ProKidney worth $768K as of Q1 2026.
  • MYDA Advisors sold 11,225 ProKidney shares in Q1 2026, an estimated $23.8K.
  • ProKidney made up 0.13% of MYDA Advisors's portfolio in Q1 2026, its #115 holding.
  • MYDA Advisors first reported a position in ProKidney in Q2 2021 and has held it in 8 quarters since.
  • MYDA Advisors's ProKidney position peaked at $2.35M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on MYDA Advisors's 13F filing for Q1 2026, filed 14 May 2026.